Common Questions on Medical Marijuana

Video

An expert discusses the most common reasons his patients ask him about medical marijuana.

Patients with cancer may seek medical marijuana for multiple reasons. In his practice, Dr. Ali J. Zarrabi, a physician at the Winship Cancer Institute and assistant professor in the Emory University School of Medicine, said in an interview with CURE® that patients often want to try cannabis to treat symptoms of cancer treatment, as well as a way to feel more in control of their treatment.

Where legal, cannabis could be promising in providing this symptomatic relief. However, patients should not assume that marijuana can actually treat their disease, as there is currently no solid evidence indicating that it can treat cancer. When patients bring this up, Zarrabi uses the opportunity to open up a broader discussion about patient values and goals of care.

Transcription:

So the most common question I get in my clinic is, ‘I'm on a lot of medicines. I'm on four different nausea pills. I'm on two different sleeping pills. I'm on opioids. I'm on whatever opioid it is – oxycodone, oxycontin, fentanyl, methadone, etc. And my friend, my family member, sometimes my oncologist suggested that I try cannabis to potentially treat many of the symptoms and distress from my disease.’

And oftentimes, it's cancer patients really at any stage who wish to reduce the number of medications that they're on, who wish to try something different. Some of my patients are really frustrated with standard pharmaceutical drugs. And they wish to have a greater sense of control over how they dose their own medications – and that's the most common reason why patients come to our practice with questions regarding cannabis.

Also, a minority of my patients, through a variety of channels might have heard that it could treat the cancer itself as a kind of chemo therapeutic. And it's really for – we interpret that as a statement of faith that, you know, this is a life and death kind of situation for me, why not try something that might help me. And in those situations, we are frank with the evidence that there is no clinical data, that it does help extend the lives of people living with cancer, it's not a cancer treatment, per se. And we find that question and opportunity to really explore hopes, goals, values, by way of that question about cannabis, as a potential treatment for their illness.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Related Content